Literature DB >> 28658560

IL-33: biological properties, functions, and roles in airway disease.

Li Yin Drake1, Hirohito Kita1,2.   

Abstract

Interleukin (IL)-33 is a key cytokine involved in type 2 immunity and allergic airway diseases. Abundantly expressed in lung epithelial cells, IL-33 plays critical roles in both innate and adaptive immune responses in mucosal organs. In innate immunity, IL-33 and group 2 innate lymphoid cells (ILC2s) provide an essential axis for rapid immune responses and tissue homeostasis. In adaptive immunity, IL-33 interacts with dendritic cells, Th2 cells, follicular T cells, and regulatory T cells, where IL-33 influences the development of chronic airway inflammation and tissue remodeling. The clinical findings that both the IL-33 and ILC2 levels are elevated in patients with allergic airway diseases suggest that IL-33 plays an important role in the pathogenesis of these diseases. IL-33 and ILC2 may also serve as biomarkers for disease classification and to monitor the progression of diseases. In this article, we reviewed the current knowledge of the biology of IL-33 and discussed the roles of the IL-33 in regulating airway immune responses and allergic airway diseases.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-33; ILC2s; Th2 cells; asthma; rhinosinusitis; type 2 immunity

Mesh:

Substances:

Year:  2017        PMID: 28658560      PMCID: PMC5492954          DOI: 10.1111/imr.12552

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  150 in total

Review 1.  Innate lymphoid cells: emerging insights in development, lineage relationships, and function.

Authors:  Hergen Spits; Tom Cupedo
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

2.  IL-33 mediates inflammatory responses in human lung tissue cells.

Authors:  Akiko Yagami; Kanami Orihara; Hideaki Morita; Kyoko Futamura; Noriko Hashimoto; Kenji Matsumoto; Hirohisa Saito; Akio Matsuda
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

3.  Platelets constitutively express IL-33 protein and modulate eosinophilic airway inflammation.

Authors:  Tomohiro Takeda; Hirotoshi Unno; Hideaki Morita; Kyoko Futamura; Maiko Emi-Sugie; Ken Arae; Tetsuo Shoda; Naoko Okada; Arisa Igarashi; Eisuke Inoue; Hiroshi Kitazawa; Susumu Nakae; Hirohisa Saito; Kenji Matsumoto; Akio Matsuda
Journal:  J Allergy Clin Immunol       Date:  2016-04-04       Impact factor: 10.793

4.  Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis.

Authors:  Matthew Lam; Laura Hull; Andrew Imrie; Kornkiat Snidvongs; David Chin; Ellie Pratt; Larry Kalish; Raymond Sacks; Peter Earls; William Sewell; Richard J Harvey
Journal:  Am J Rhinol Allergy       Date:  2015 May-Jun       Impact factor: 2.467

5.  Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.

Authors:  Mélanie Pichery; Emilie Mirey; Pascale Mercier; Emma Lefrancais; Arnaud Dujardin; Nathalie Ortega; Jean-Philippe Girard
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

6.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

7.  Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice.

Authors:  Koubun Yasuda; Taichiro Muto; Tatsukata Kawagoe; Makoto Matsumoto; Yuki Sasaki; Kazufumi Matsushita; Yuko Taki; Shizue Futatsugi-Yumikura; Hiroko Tsutsui; Ken J Ishii; Tomohiro Yoshimoto; Shizuo Akira; Kenji Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

8.  Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.

Authors:  L Y Drake; K Iijima; H Kita
Journal:  Allergy       Date:  2014-06-17       Impact factor: 13.146

9.  Enhanced innate type 2 immune response in peripheral blood from patients with asthma.

Authors:  Kathleen R Bartemes; Gail M Kephart; Stephanie J Fox; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2014-09       Impact factor: 10.793

10.  An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor.

Authors:  Maho Suzukawa; Motoyasu Iikura; Rikiya Koketsu; Hiroyuki Nagase; Chise Tamura; Akiko Komiya; Susumu Nakae; Kouji Matsushima; Ken Ohta; Kazuhiko Yamamoto; Masao Yamaguchi
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

View more
  59 in total

1.  IL-33 induces production of autoantibody against autologous respiratory epithelial cells: a potential mechanism for the pathogenesis of COPD.

Authors:  Qin Li; Yue Hu; Yan Chen; Zhe Lv; Jingjing Wang; Gao An; Xiaonan Du; Huating Wang; Chris J Corrigan; Wei Wang; Sun Ying
Journal:  Immunology       Date:  2019-03-27       Impact factor: 7.397

Review 2.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

3.  Tollip Inhibits ST2 Signaling in Airway Epithelial Cells Exposed to Type 2 Cytokines and Rhinovirus.

Authors:  Azzeddine Dakhama; Reem Al Mubarak; Nicole Pavelka; Dennis Voelker; Max Seibold; Julie G Ledford; Monica Kraft; Liwu Li; Hong Wei Chu
Journal:  J Innate Immun       Date:  2019-03-29       Impact factor: 7.349

4.  Antigen-specific airway IL-33 production depends on FcγR-mediated incorporation of the antigen by alveolar macrophages in sensitized mice.

Authors:  Takeshi Nabe; Masaya Matsuda; Tomoki Ishida; Nau Tsujimoto; Hitomi Kido; Haruna Kanaya; Hiromu Takahashi; Naoki Takemoto; Miku Nomura; Keiichi Ishihara; Satoshi Akiba; Nobuaki Mizutani
Journal:  Immunology       Date:  2018-04-19       Impact factor: 7.397

Review 5.  ILC2s in infectious diseases and organ-specific fibrosis.

Authors:  Markus Kindermann; Lisa Knipfer; Imke Atreya; Stefan Wirtz
Journal:  Semin Immunopathol       Date:  2018-03-26       Impact factor: 9.623

Review 6.  Proinflammatory Pathways in the Pathogenesis of Asthma.

Authors:  R Stokes Peebles; Mark A Aronica
Journal:  Clin Chest Med       Date:  2019-03       Impact factor: 2.878

Review 7.  Inflammatory Profiles of the Interleukin Family and Network in Cerebral Hemorrhage.

Authors:  Lei Ye; Lu Gao; Hongwei Cheng
Journal:  Cell Mol Neurobiol       Date:  2018-07-19       Impact factor: 5.046

8.  CXCR6+ST2+ memory T helper 2 cells induced the expression of major basic protein in eosinophils to reduce the fecundity of helminth.

Authors:  Kazushige Obata-Ninomiya; Kenji Ishiwata; Hisanobu Nakano; Yusuke Endo; Tomomi Ichikawa; Atsushi Onodera; Kiyoshi Hirahara; Yoshitaka Okamoto; Hirotaka Kanuka; Toshinori Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

9.  The effects of interleukin-33 on airways collagen deposition and matrix metalloproteinase expression in a murine surrogate of asthma.

Authors:  Gao An; Xin Zhang; Wenjun Wang; Qiong Huang; Yan Li; Shan Shan; Chris J Corrigan; Wei Wang; Sun Ying
Journal:  Immunology       Date:  2018-02-18       Impact factor: 7.397

10.  Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity.

Authors:  Ophir Shani; Tatiana Vorobyov; Lea Monteran; Dor Lavie; Noam Cohen; Yael Raz; Galia Tsarfaty; Camila Avivi; Iris Barshack; Neta Erez
Journal:  Cancer Res       Date:  2020-10-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.